FTO and obesity disorder: In a diet-induced obesity mouse model treatment with entacapone, FOXO1, as a direct substrate of FTO, can induce intrahepatic gluconeogenesis and adipose tissue thermogenesis, resulting in weight loss and a decrease in the fasting blood glucose concentration [102].